CGEN Compugen Ltd

Compugen Ltd. (NASDAQ:CGEN) today announced that the Company plans to host a live conference call and webcast at 10:00 AM EST on Thursday, August 2, 2007 to review second quarter 2007 results. The quarterly results will be released prior to the conference call. To access the conference call, please dial 1-888-281-1167 from the US or +972-3-918-0610 internationally. The call will also be available via live webcast through Compugen�s Website, located at www.cgen.com. A replay of the conference call will be available approximately two hours after the completion of the live conference call. To access the replay, please dial 1-888-782-4291 from the US or +972-3�925-5901. The replay will be available until 12 noon EST on August 6, 2007. About Compugen Compugen�s mission is to be the world leader in the discovery and licensing of product candidates to the drug and diagnostic industry. The Company�s powerful discovery engines enable the predictive discovery of numerous potential therapeutics and diagnostic biomarkers. This capability results from the Company�s decade-long pioneering efforts in the deeper understanding of important biological phenomena at the molecular level through the incorporation of ideas and methods from mathematics, computer science and physics into biology, chemistry and medicine. To date, Compugen�s product discovery efforts and its initial discovery engines have focused mainly within the areas of cancer, immune-related and cardiovascular diseases. The Company's primary commercialization pathway for its therapeutic and diagnostic product candidates is to enter into milestone and revenue sharing out-licensing and joint development agreements with leading companies. Compugen has established an agricultural biotechnology affiliate � Evogene, and a small-molecule drug discovery affiliate � Keddem Bioscience. For additional information, please visit Compugen's corporate Website at www.cgen.com.